ProCE Banner Activity

Planning Ahead: Development of a Seizure Action Plan With Rescue Medications

Slideset

Slides from the epilepsy presentation at the 2022 Movement Disorders+ Summit.

Released: September 22, 2022

Expiration: September 21, 2025

Share

Faculty

Jacqueline French

Jacqueline French, MD

Professor
Department of Epilepsy/Neurology
NYU Grossman School of Medicine
New York, New York

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from

Neurelis Inc

Faculty Disclosure

Primary Author

Jacqueline French, MD

Professor
Department of Epilepsy/Neurology
NYU Grossman School of Medicine
New York, New York

Jacqueline French, MD: consultant/advisor/speaker (paid to institution):  Aeonian/Aeovian, Alterity Therapeutics, Anavex, Arvelle Therapeutics, Athenen Therapeutics/Carnot Pharma, Autifony Therapeutics, Baergic Bio, Biogen, Biohaven, BioMarin, BioXcel Therapeutics, Bloom Science Inc., BridgeBio Pharma, Camp4 Therapeutics, Cerebral Therapeutics, Cerevel, Coda Biotherapeutics, Corlieve Therapeutics, Crossject, Eisai, Eliem Therapeutics, Encoded Therapeutics, Engage Therapeutics, Engrail, Epalex, Epihunter, Epiminder, Epitel, Equilibre BioPharmaceuticals, Greenwich Biosciences, Grin Therapeutics, GW Pharma, Janssen, Jazz, Knopp Biosciences, Lipocine, LivaNova, Longboard, Lundbeck, Marinus, Mend Neuroscience, Merck, NeuCyte, Neumirna Therapeutics, Neurocrine, Neuroelectrics, Neuropace, NxGen Medicine., Ono, Otsuka, Ovid Therapeutics , Paladin Labs, Passage Bio, Pfizer, Praxis, PureTech LTY, Rafa Laboratories, SK Life Sciences, Sofinnova, Stoke, Supernus, Synergia Medical, Takeda, UCB , Ventus Therapeutics, Xenon, Xeris, Zogenix, Zynerba; research support: the Epilepsy Study Consortium (Funded by, Eisai, Engage, Lundbeck, Pfizer, SK Life Science, Sunovion, UCB), the Epilepsy Study Consortium/Epilepsy Foundation (Funded by UCB); other financial or material support: Arvelle Therapeutics, NeuCyte, Neurocrine, Praxis, Xenon.